Lincoln Alternative Strategies LLC - 12 Sep 2025 SCHEDULE 13G Report for Silexion Therapeutics Corp. Ordinary Shares, par value $0.0009 per share (SLXN)

Filing Manager: Lincoln Alternative Strategies LLC
Reporting Manager: Lincoln Alternative Strategies LLC
Security: Silexion Therapeutics Corp. Ordinary Shares, par value $0.0009 per share
Symbol: SLXN
Shares outstanding: 2,123,786 shares
Disclosed Ownership: 131,250 shares
Ownership: 6.2%
Form type: SCHEDULE 13G
Filing time: 15 Sep 2025, 12:31:34 UTC
Date of event: 12 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lincoln Alternative Strategies LLC	6.2%	131,250	131,250	0	/s/ Stephen Temes	Stephen Temes/Managing Member